Regulatory & Legal

Food Bank For NYC's new program empowers students with lived experience to tackle the widespread, yet often invisible, issue of college food insecurity.

After a four-year regulatory journey, AquaBoreal's massive salmon farm gets key approval, promising to boost Quebec's food security and revitalize a region.

Founded by Squarepoint principals, STG Group is launching STG Securities, aiming to challenge electronic market-making giants like Citadel and Virtu.

Safepoint MGA partners with Solstice Innovations, adopting the Equinox™ platform to navigate complex NFIP rules and enhance service in coastal markets.

A new partnership turns your smartphone into a motion lab, creating a powerful loop to assess and correct the root causes of chronic pain from home.

After a 1-for-12 reverse stock split saved it from delisting, Cre8 Enterprise must now prove its strategic pivot is more than a temporary fix.

The wholesale distributor is integrating its offline supply chain with a B2B digital platform, aiming for massive growth in China's tech-driven health market.

Berkshire Hathaway Specialty Insurance appoints Rory O’Broin to lead its transactional liability unit, a strategic move to capture a rebounding M&A market.

Amid stellar growth and strong analyst ratings, the drive-thru coffee chain heads to a key investor forum to chart its path to national dominance.

After a chaotic 2025, businesses face a new normal of complex digital taxes and aggressive enforcement, with only minor glimmers of relief in 2026.

As Sera Prognostics preps its year-end report, investors watch to see if its groundbreaking preterm birth test can deliver financial health.

Data shows Achieve Life Sciences' drug helps smokers quit, even after multiple failed attempts with other drugs, as a critical FDA decision looms.

A new analysis reveals major banks lend to California's Latino homebuyers at less than half the rate of nonbanks, threatening economic mobility.

After solving a key manufacturing flaw, CervoMed advances its promising dementia drug, neflamapimod, to a Phase 3 trial with an optimized dose.

VC firm Halogen Ventures injects capital into nine Alabama startups, betting on female entrepreneurs to transform the state's burgeoning tech ecosystem.

FDA approves Glenmark's generic inhaler with 180-day exclusivity, promising lower costs for millions and disrupting a major respiratory drug market.

A landmark draft permit advances a first-of-its-kind project in Louisiana, promising carbon-negative power, SAF, and a major economic boost for the region.

A new partnership integrates advanced AI for brain lesion tracking into a global imaging network, promising safer Alzheimer's treatments and faster diagnostics.

UCLA forecast predicts 3% GDP growth driven by massive AI spending and tax cuts, but California's job market paradox reveals a widening economic divide.

A new UK facility, backed by government funds, will be the only one of its kind, aiming to accelerate drug development and boost domestic life sciences.